AIM Clinical Appropriateness Guidelines and Cancer Treatment Pathways

Home 9 Current Genetic Testing Guidelines

Current Genetic Testing Guidelines

The foundation of our solution platform for specialty benefits management is our clinical appropriateness guidelines. AIM Clinical Appropriateness Guidelines for Genetic Testing are developed through a rigorous process integrating evidence-based literature with expert review.

The Guidelines do not address coverage, benefit or other plan specific issues. Applicable federal and state coverage mandates take precedence over these clinical guidelines. If requested by a health plan, AIM will review requests based on health plan medical policy/guidelines in lieu of the AIM Guidelines.

Guidelines developed by, and used with permission from, Informed Medical Decisions, Inc. (dba InformedDNA®).
© 2020 Informed Medical Decisions, Inc. All rights reserved.